Drugs / Sulforadex
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02055716 | Jan → Apr 2014 | prostate cancer | Evgen Pharma | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01948362 Comparator | Nov 2012 → Feb 2013 | prostate cancer | Evgen Pharma | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sulforadex | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02055716 ↗ |